Nuvectis Pharma, Inc. (NVCT) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $18.41M | +89.6% |
| 2024 | $9.71M | -20.4% |
| 2023 | $12.20M | -14.2% |
| 2022 | $14.22M | +229.2% |
| 2021 | -$11.01M | -109980.0% |
| 2020 | -$10.0K | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $18.41M | +89.6% |
| 2024 | $9.71M | -20.4% |
| 2023 | $12.20M | -14.2% |
| 2022 | $14.22M | +229.2% |
| 2021 | -$11.01M | -109980.0% |
| 2020 | -$10.0K | — |